Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BIDU stock price vs ALNY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALNY's multiple
Needs ALNY P/E.
Implied fair value · at BIDU's multiple
Needs BIDU P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BIDU FY 2025 (ended Dec 31, 2025) · ALNY FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Baidu, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
ALNYLAM PHARMACEUTICALS, INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.18x
5.22x
Net debt / EBITDA
Leverage against operating earnings
-4.00x
4.13x
Cash and equivalents
Liquid reserves on the balance sheet
$16.48B
$1.66B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
BIDU vs MSFT
Alphabet Inc.
BIDU vs GOOGL
Meta Platforms, Inc.
BIDU vs META
ADOBE INC.
BIDU vs ADBE
Salesforce, Inc.
BIDU vs CRM
Moderna, Inc.
BIDU vs MRNA
Sarepta Therapeutics, Inc.
BIDU vs SRPT
VERTEX PHARMACEUTICALS INC / MA
BIDU vs VRTX
BioNTech SE
BIDU vs BNTX
ACADIA PHARMACEUTICALS INC
BIDU vs ACAD
$7.00B
$4.12B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
